Freedom of Information request about Deferasirox and Lacosamide ADR follow up questionnaire (FOI-20-568)
Published 24 March 2021
© Crown copyright 2021
This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit nationalarchives.gov.uk/doc/open-government-licence/version/3 or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: psi@nationalarchives.gov.uk.
Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.
This publication is available at https://www.gov.uk/government/publications/freedom-of-information-responses-from-the-mhra-week-commencing-18-january-2021/freedom-of-information-request-about-deferasirox-and-lacosamide-adr-follow-up-questionnaire-foi-20-568
Thank you for your Freedom of Information (FOI) request dated 17th December 2020, where you requested the following information:
‘ADR follow up questionnaires for Deferasirox RMP from MHRA and ADR follow up questionnaires for Lacosamide RMP from MHRA’
A copy of the information, which can be disclosed, is attached.
We hope the information provided is helpful, but if you are dissatisfied with the handling of your request, you have the right to ask for an internal review. Internal review requests should be submitted within two months of the date of this response; and can be addressed to this email address
Yours sincerely,
FOI Team,
Vigilance and Risk Management of Medicines Divisio